Abstract: A reactor and a process for carrying out parallel reactions on solids is described. The reactor comprises at least a sample holder block (1) with a multiplicity of reaction vessels (2a-2k), a heated support structure (3) and a cover (8, 9, 10) sealing all the reaction vessels (2a-2k). The cover (8, 9, 10) contains feed lines (4a-4k) and discharge lines (5a-5k) to each sample vessel (2a-2k). The feed lines (4a-4k) and/or the discharge lines (5a-5k) are joined together by means of feed and discharge channels (7, 8) running crosswise to said lines. The feed and discharge channels (7, 8) end in main fluid feed lines (11) and discharge lines (12).

Abstract: By using a new method 2-(2-hydroxyethoxy)-ethanol ester is produced from flufenamic acid as a result of direct esterification with diol with an excess of 8-15 mol diol per mol flufenamic acid without concurrent removal of water.

Abstract: Novel diethylene glycol monoester of antirheumatically effective acids, e.g., lonazolac and diclofenac and others are disclosed which have inflammation inhibitory properties superior to the corresponding acid base forms. They may be produced through direct esterification without elimination of water and are suitable in the fight against diseases of the rheumatic complex.

Abstract: The invention relates to the use of naproxen lysinate, ketoprofen lysinate and/or diclofenac lysinate in the form of an injectable solution in the treatment of inflammations and rheumatic disorders, and to injectable solutions containing the anti-inflammatory active compound naproxen, ketoprofen or diclofenac in the form of its lysinate.

Abstract: At least one barbiturate or one of its pharmaceutically acceptable salts is combined with cinnarizine or flunarizine or one of their pharmaceutically acceptable salts to provide a hypnotic requiring lower dosages of barbiturates to produce the same effect as the barbiturate alone.

Abstract: An apparatus for automatically determining the surface tension by the stalagmometer principle using a pipette containing a test volume, having a drop face at its lower end and is provided with three light barriers. The three light barriers are connected to an evaluation circuit which counts the number of whole drops and also determines the fractions of whole drops pertaining to the test volume.

Abstract: The object of the present invention are novel aminobenzoic acid derivatives having the general formula: ##STR1## wherein R.sub.1 is hydrogen, chlorine, hydroxy, acetoxy or C.sub.1 -C.sub.3 -alkoxy;R.sub.2 is hydrogen, chlorine or sulfamoyl;R.sub.5 is hydrogen or combined with R.sub.6 a C.sub.2 -C.sub.3 -alkylene;Y is the group ##STR2## or in ortho-position together with the hydrogen atom on the nitrogen and with R.sub.5 the group ##STR3## wherein R.sub.3 is hydrogen or methyl;R.sub.4 is hydrogen, C.sub.1 -C.sub.3 -alkyl, or with Z substituted phenoxy; andZ is hydrogen, halogen or trifluoromethyl;X is C.sub.1 -C.sub.3 -alkylene forming, if necessary, under substitution with R.sub.6 a 5- or 6-link aliphatic or aromatic ring system;R.sub.6 is C.sub.1 -C.sub.4 -alkyl or in combination with X a C.sub.3 -C.sub.4 -cycloalkylene or cycloarylene;R.sub.7 is hydrogen, C.sub.1 -C.sub.3 -alkyl, formyl, the group Y, or together with R.sub.6 a C.sub.4 -C.sub.5 -cycloalkylene, or together with X and R.sub.6 pyridylmethyl;R.

Abstract: The use of etofylline clofibrate for the treatment of elevated serum levels of uric acid in humans is disclosed.

Abstract: The use of the combination of clofibrinic acid or clofibrate with cinnarizine for the treatment of hypertension in humans is disclosed.

Abstract: There are disclosed N-acyl substituted benzamides of the general formula: ##STR1## wherein: X is carbon or nitrogen;R.sub.1 is hydrogen, alkyl, halogen, trifluoromethyl, alkoxy, phenoxy or acetoxy;Y is the radical --O--, --NH-- or --S--;Z is an alkylene group containing 1 to 5 carbon atoms, or an alkenylene group containing 1 to 5 carbon atoms, either of which group may be unsubstituted or substituted by an alkyl, alkenyl, phenyl, cycloalkyl, acetyl, amino or halogenphenoxy group;R.sub.2 is hydrogen, an alkyl group containing 1 to 4 carbon atoms, an alkenyl group containing 1 to 4 carbon atoms in which either the alkyl or the alkenyl group may be unsubstituted or substituted with a halogen, phenyl or halogenphenyl substituent; andThe value of n, m, and p may each be 0 or 1, and in the case of p=1, pharmaceutically acceptable salts thereof.Also disclosed is a method for making such compounds and pharmaceutical compositions containing such compounds.

Abstract: A device for the storage of sample containers comprises a holder for receiving the sample containers and a covering, whereby a common covering is provided for all the sample containers which seals them individually and simultaneously.

Abstract: Phenoxyalkylcarboxylic acid amides and their preparation is described. These compounds are useful as antihypercholesteremic agents.

Abstract: Salts of 1-cinnamyl-4-diphenylmethyl piperazine and their method of preparation of compositions thereof is described. These compounds have antihypercholesteremic activity.

Abstract: A novel pharmaceutically useful compound, the p-chlorophenoxyisobutyrate salt of 4-(p-chlorophenoxyacetyl-amino)-benzene carboxylic acid diethylaminoethyl ester, is disclosed, which has superior antilipemic and anticholesteremic properties.

Abstract: Phenoxyalkanecarboxylic acids are esterified with 7-(2-hydroxyethyl) theophylline or 7-(2,3-dihydroxypropyl) theophylline. The resulting esters have excellent antilipemic and anticholesterolemic properties as well as pronounced peripheral and vasodilative effect.